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We commend Chmielewska and colleagues for undertaking a timely and comprehensive systematic 
review on a topic of pivotal global health importance.1 The increase in maternal mortality and stillbirth 
during the COVID-19 pandemic, particularly in low-resource settings, is of considerable concern. 
Although a considerable number of studies were collated, many have substantial risk of bias. For 
example, of the 18 included studies assessing the link between the pandemic and preterm birth, only 
two had a quasi-experimental design, many lacked methodological detail, few adjusted for potential 
confounding, and only three included population-level data. Only one study accounted for time trends in 
preterm birth,2 which is important to ensure that any changes during the pandemic are independent of 
underlying temporal patterns. Of the 18 studies, this study also had the largest sample size and the 
maximum Newcastle-Ottawa score, indicating high quality. As systematic reviews serve an important 
role in summarising the best available evidence, it is remarkable that the current meta-analysis excluded 
this study. Using inverse-variance rather than Mantel-Haenszel weighting allows for its inclusion,3 with 
limited impact on the association between the COVID-19 pandemic and preterm birth (OR=0∙90 
[95%CI:0∙83−0∙98; 13 studies; n=1,919,726 (Figure)], rather than 0∙91 [95%CI:0∙84−0∙99];1 12 studies; 
n=852,854). 
Thorough assessment of how the COVID-19 pandemic and lockdowns have affected maternal and 
perinatal outcomes is crucial and has important public health implications. Accordingly, more robust 
studies are needed based on high-quality longitudinal data. Ideally population-level data should be used, 
as the pandemic likely influenced health seeking behaviors and access to maternity care, leading to 
potential ascertainment bias if institutional-level data is relied on.4 Also, inclusion of both pregnancy and 
neonatal data (rather than just one or the other) is important to assess any disparate impact of the 
pandemic on competing events (e.g. stillbirth and preterm birth). Applying appropriate quasi-
experimental designs to population-level maternity and birth data, accounting for underlying temporal 
Manuscript Click here to view linked References
trends in the outcomes of interest, has the highest potential to attribute causality and minimise 
confounding.  
Now is the time as a perinatal research community to seize opportunities to collaboratively take 
advantage of the unique natural experiment provided by the COVID-19 pandemic to accelerate progress 
in maternal and child health globally. We call on researchers to undertake robust studies and contribute 
to joint international efforts such as the international Perinatal Outcomes in the Pandemic (iPOP) study.5 
Together we can learn from recent experiences and start identifying mechanisms that may contribute to 
a healthier start for future generations. 
   
Figure: Forest plot of pooled ORs for the association between start of the COVID-19 pandemic and the 
incidence of preterm birth (<37 weeks gestation) within high-income countries. Results from random-
effects inverse variance meta-analysis. ORs derived from Chmielewska et al.1 and Been et al.2 
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